Term Name: (1R,2R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
Synonyms: (1R,2R)-2-hexadecanoylamino-3-morpholino-1-phenylpropan-1-ol, (1R,2R)-3-morpholino-2-palmitoylamino-1-phenylpropan-1-ol, (1R,2R)-PPMP, (1R,threo)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, (1R,threo)-PPMP, (R,R)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, (R,R)-PPMP, D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, D-threo-PPMP, N-[(1R,2R)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide, N-[(1R,2R)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]palmitamide, N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]hexadecanamide, N-[(1R,2R)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]palmitamide
Definition: An N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide in which both stereocentres have R configuration.
Ontology: ChEBI [CHEBI:75126]  ( EBI )

Relationships
is a type of: N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide
has_role: EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
inverse has_part: DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
inverse is_enantiomer_of: (1S,2S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol
is_enantiomer_of: (1S,2S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol